Nifty
:
15783.20
Sensex
:
52538.14
-86.05 (-0.54%)
-234.91 (-0.45%)
Nifty
Sensex
:
:
15783.20
52538.14
-86.05 (-0.54%)
-234.91 (-0.45%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
54/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
747.35
15-Jun-2021
  • Open
  • High
  • Low
  • Previous Close
  •  710.00
  •  755.00
  •  705.00
  •  711.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  25916
  •  191.21
  •  835.00
  •  275.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 687.20
  • 19.25
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 781.63
  • 0.23%
  • 3.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.26%
  • 3.21%
  • 23.59%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.94%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.21
  • -2.81
  • -1.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.20
  • -1.34
  • 7.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.37
  • 0.85
  • 22.21

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.94
  • 23.49
  • 13.87

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.53
  • 2.69
  • 1.80

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.25
  • 20.49
  • 24.10

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
61.77
46.15
33.85%
65.52
53.78
21.83%
54.89
50.32
9.08%
48.49
51.33
-5.53%
Expenses
49.52
32.77
51.11%
50.27
44.45
13.09%
45.19
44.89
0.67%
36.19
43.83
-17.43%
EBITDA
12.25
13.39
-8.51%
15.25
9.33
63.45%
9.70
5.43
78.64%
12.30
7.51
63.78%
EBIDTM
19.83%
29.00%
23.28%
17.35%
17.67%
10.79%
25.36%
14.63%
Other Income
0.88
0.38
131.58%
0.25
2.91
-91.41%
2.13
0.08
2,562.50%
0.36
0.09
300.00%
Interest
3.09
3.41
-9.38%
2.92
2.96
-1.35%
3.71
3.30
12.42%
3.00
3.21
-6.54%
Depreciation
2.38
2.07
14.98%
2.09
2.07
0.97%
2.04
2.06
-0.97%
2.04
2.07
-1.45%
PBT
7.66
8.29
-7.60%
10.49
7.22
45.29%
6.08
0.14
4,242.86%
7.62
2.33
227.04%
Tax
1.21
3.09
-60.84%
2.02
-0.31
-
0.42
-0.49
-
1.98
-0.20
-
PAT
6.46
5.19
24.47%
8.47
7.53
12.48%
5.66
0.63
798.41%
5.64
2.53
122.92%
PATM
10.46%
11.25%
12.92%
14.00%
10.31%
1.25%
11.63%
4.92%
EPS
8.76
7.92
10.61%
12.80
11.62
10.15%
8.85
1.83
383.61%
8.44
5.62
50.18%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
230.67
201.59
183.75
209.50
216.66
232.43
201.88
195.07
173.51
157.72
252.08
Net Sales Growth
14.43%
9.71%
-12.29%
-3.30%
-6.78%
15.13%
3.49%
12.43%
10.01%
-37.43%
 
Cost Of Goods Sold
78.58
51.97
58.82
57.75
55.66
71.38
79.51
76.68
74.95
94.19
135.16
Gross Profit
152.09
149.62
124.94
151.75
160.99
161.06
122.37
118.39
98.56
63.52
116.91
GP Margin
65.94%
74.22%
67.99%
72.43%
74.31%
69.29%
60.62%
60.69%
56.80%
40.27%
46.38%
Total Expenditure
181.17
165.93
181.48
184.98
184.29
194.28
183.91
171.01
156.71
170.56
228.45
Power & Fuel Cost
-
11.49
9.70
8.41
9.77
10.83
8.36
10.04
10.03
10.27
11.47
% Of Sales
-
5.70%
5.28%
4.01%
4.51%
4.66%
4.14%
5.15%
5.78%
6.51%
4.55%
Employee Cost
-
44.28
45.69
44.65
40.00
36.30
32.64
31.14
27.27
23.70
22.22
% Of Sales
-
21.97%
24.87%
21.31%
18.46%
15.62%
16.17%
15.96%
15.72%
15.03%
8.81%
Manufacturing Exp.
-
24.01
22.45
27.46
31.30
31.28
21.69
16.38
11.80
12.36
29.15
% Of Sales
-
11.91%
12.22%
13.11%
14.45%
13.46%
10.74%
8.40%
6.80%
7.84%
11.56%
General & Admin Exp.
-
14.05
17.57
18.93
18.86
14.75
13.52
11.72
11.33
9.75
10.40
% Of Sales
-
6.97%
9.56%
9.04%
8.70%
6.35%
6.70%
6.01%
6.53%
6.18%
4.13%
Selling & Distn. Exp.
-
12.28
17.71
18.27
16.70
12.05
10.87
10.06
7.65
5.89
7.90
% Of Sales
-
6.09%
9.64%
8.72%
7.71%
5.18%
5.38%
5.16%
4.41%
3.73%
3.13%
Miscellaneous Exp.
-
7.86
9.54
9.51
11.99
17.69
17.32
14.98
13.68
14.40
7.90
% Of Sales
-
3.90%
5.19%
4.54%
5.53%
7.61%
8.58%
7.68%
7.88%
9.13%
4.82%
EBITDA
49.50
35.66
2.27
24.52
32.37
38.15
17.97
24.06
16.80
-12.84
23.63
EBITDA Margin
21.46%
17.69%
1.24%
11.70%
14.94%
16.41%
8.90%
12.33%
9.68%
-8.14%
9.37%
Other Income
3.62
3.46
2.67
3.49
3.32
3.19
12.59
4.90
3.34
2.94
5.66
Interest
12.72
12.88
11.82
11.87
11.84
12.33
14.53
15.63
15.28
13.55
10.38
Depreciation
8.55
8.27
7.99
7.42
7.47
11.89
11.49
9.36
8.91
7.67
7.74
PBT
31.85
17.97
-14.87
8.74
16.37
17.13
4.54
3.98
-4.05
-31.12
11.17
Tax
5.63
2.09
-1.84
0.10
1.60
1.91
-0.89
1.28
2.27
1.35
-0.23
Tax Rate
17.68%
11.63%
12.37%
1.14%
9.77%
11.15%
-19.60%
32.16%
-56.05%
-4.34%
-2.06%
PAT
26.23
15.88
-13.01
8.70
14.77
15.22
5.44
2.70
-6.32
-32.47
11.40
PAT before Minority Interest
26.23
15.88
-13.03
8.64
14.77
15.22
5.44
2.70
-6.32
-32.47
11.40
Minority Interest
0.00
0.00
0.02
0.06
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.37%
7.88%
-7.08%
4.15%
6.82%
6.55%
2.69%
1.38%
-3.64%
-20.59%
4.52%
PAT Growth
65.18%
-
-
-41.10%
-2.96%
179.78%
101.48%
-
-
-
 
EPS
28.51
17.26
-14.14
9.46
16.05
16.54
5.91
2.93
-6.87
-35.29
12.39

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
183.02
158.09
168.91
152.44
74.03
59.20
56.53
52.17
58.52
91.56
Share Capital
9.19
9.18
9.18
9.04
8.52
8.47
8.45
8.05
8.05
8.05
Total Reserves
173.35
148.31
159.18
141.36
65.51
50.73
48.08
43.27
50.47
83.51
Non-Current Liabilities
7.51
2.71
6.72
7.60
70.83
82.04
89.97
99.37
71.58
67.61
Secured Loans
0.09
0.14
0.01
0.47
15.89
18.83
24.47
32.08
2.78
0.06
Unsecured Loans
11.76
9.21
11.48
11.93
47.52
55.81
52.30
59.72
62.13
60.83
Long Term Provisions
0.00
0.00
0.00
0.00
0.54
0.49
0.46
0.39
0.30
1.24
Current Liabilities
154.81
146.69
124.94
124.17
129.66
135.61
137.09
120.36
150.31
134.08
Trade Payables
29.68
35.04
30.55
31.63
34.90
60.15
56.97
51.65
59.03
64.17
Other Current Liabilities
46.86
43.72
29.76
38.13
37.04
16.51
23.68
14.81
12.93
10.60
Short Term Borrowings
76.61
66.86
63.73
53.45
51.88
53.78
52.74
50.55
75.35
54.15
Short Term Provisions
1.66
1.07
0.90
0.95
5.83
5.17
3.71
3.34
3.00
5.16
Total Liabilities
345.34
307.47
300.51
284.21
274.52
276.85
283.59
271.90
280.41
293.25
Net Block
116.31
123.41
125.90
123.71
117.35
122.32
121.26
123.66
133.75
118.75
Gross Block
147.14
146.06
140.78
131.17
212.16
206.19
192.01
185.14
187.89
165.44
Accumulated Depreciation
30.83
22.66
14.87
7.46
94.80
83.87
70.75
61.47
54.14
46.69
Non Current Assets
164.85
157.61
157.47
159.81
141.68
143.38
149.17
148.01
151.01
149.69
Capital Work in Progress
7.54
2.45
2.47
8.95
5.79
3.50
11.63
10.70
6.77
16.89
Non Current Investment
35.47
26.64
24.38
21.83
5.64
4.59
3.59
3.59
0.51
0.51
Long Term Loans & Adv.
2.91
2.67
2.39
3.01
12.19
12.70
12.11
9.79
9.54
12.02
Other Non Current Assets
2.62
2.45
2.33
2.30
0.70
0.28
0.58
0.27
0.45
1.52
Current Assets
180.49
149.86
143.04
124.40
132.83
133.47
134.44
123.89
129.40
143.57
Current Investments
0.00
0.00
0.00
1.05
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
54.61
53.63
49.58
48.44
58.26
62.30
66.34
54.70
47.23
46.26
Sundry Debtors
102.48
72.91
68.63
48.25
47.57
45.56
39.58
32.35
48.13
66.57
Cash & Bank
5.29
3.45
6.91
8.62
14.30
8.70
6.57
12.21
6.70
6.18
Other Current Assets
18.11
5.42
5.34
5.32
12.70
16.92
21.94
24.63
27.35
24.55
Short Term Loans & Adv.
12.28
14.45
12.57
12.72
11.34
15.58
20.57
23.22
26.34
22.62
Net Current Assets
25.68
3.18
18.09
0.23
3.18
-2.14
-2.66
3.53
-20.92
9.49
Total Assets
345.34
307.47
300.51
284.21
274.51
276.85
283.61
271.90
280.41
293.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
0.33
10.92
7.86
-1.51
25.76
19.09
8.35
4.45
-14.33
4.49
PBT
26.87
-12.60
11.33
17.56
30.52
19.85
19.61
11.23
-17.57
20.55
Adjustment
9.33
16.74
14.93
15.92
10.05
10.48
8.47
7.72
6.80
6.26
Changes in Working Capital
-35.63
7.08
-19.05
-35.16
-0.57
2.40
-2.82
3.04
11.34
-11.62
Cash after chg. in Working capital
0.57
11.22
7.21
-1.67
40.00
32.73
25.26
22.00
0.57
15.19
Interest Paid
0.00
0.00
0.00
0.00
-12.33
-14.53
0.00
0.00
0.00
0.00
Tax Paid
-0.24
-0.30
0.65
0.16
-1.91
0.89
-1.28
-2.27
-1.35
-0.40
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.47
-3.72
-0.04
-4.14
-7.17
-6.27
-6.71
-4.56
-11.76
-9.17
Net Fixed Assets
-6.16
-5.34
-3.11
20.82
-6.64
-2.13
-3.68
2.13
-7.75
-11.11
Net Investments
0.06
-0.01
1.01
-1.33
0.01
-0.23
0.00
-3.09
-0.01
0.00
Others
0.63
1.63
2.06
-23.63
-0.54
-3.91
-3.03
-3.60
-4.00
1.94
Cash from Financing Activity
6.72
-9.94
-9.11
5.27
-13.29
-17.96
1.89
29.33
4.93
-2.50
Net Cash Inflow / Outflow
1.59
-2.74
-1.29
-0.38
5.31
-5.14
3.52
29.23
-21.16
-7.18
Opening Cash & Equivalents
1.75
4.49
5.78
6.16
-39.67
-34.53
-38.05
-67.28
-46.12
-39.01
Closing Cash & Equivalent
3.34
1.75
4.49
5.78
-34.36
-39.67
-34.53
-38.05
-67.28
-46.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
198.67
171.54
183.39
166.38
86.94
69.91
66.90
63.75
72.69
113.74
ROA
4.86%
-4.29%
2.95%
5.29%
5.52%
1.94%
0.97%
-2.29%
-11.32%
4.00%
ROE
9.34%
-8.00%
5.42%
13.16%
22.85%
9.40%
5.00%
-11.50%
-43.27%
13.00%
ROCE
11.81%
-1.25%
8.52%
12.92%
14.69%
9.45%
9.53%
5.39%
-8.28%
10.20%
Fixed Asset Turnover
1.38
1.28
1.56
1.32
1.13
1.03
1.04
0.94
0.91
1.57
Receivable days
158.78
140.57
100.75
77.33
72.04
76.05
66.90
83.91
130.33
87.40
Inventory Days
97.99
102.51
84.49
86.11
93.26
114.91
112.58
106.28
106.24
62.74
Payable days
75.58
71.78
69.42
73.88
99.57
126.74
123.69
137.24
142.68
90.57
Cash Conversion Cycle
181.20
171.29
115.83
89.56
65.73
64.22
55.79
52.95
93.89
59.57
Total Debt/Equity
0.55
0.52
0.48
0.55
1.73
2.37
2.61
3.02
2.57
1.35
Interest Cover
2.40
-0.26
1.74
2.38
2.39
1.31
1.25
0.74
-1.30
2.08

Annual Reports:

FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.